* J&J targets COVID-19 late-stage trial outcomes by January
* Aussie tech stocks hit report excessive
* Infratil soars after rejecting $3.78 bln buyout provide
Dec 9 (Reuters) – Australian shares prolonged their rally to a seventh session on Wednesday, monitoring positive aspects within the Wall Street after encouraging vaccine information boosted U.S. indexes to a report excessive, with home healthcare and know-how stocks main the cost.
Main averages on Wall Street touched report ranges on Tuesday after Johnson & Johnson turned the most recent in a slew of firms to report constructive outcomes for its COVID-19 vaccine candidate.
The S&P/ASX 200 index gained as much as 0.8% and touched 6742.5 points, its highest degree since Feb. 26.
Including to the constructive sentiment, a measure of Australian shopper sentiment climbed for the fourth straight month in December to a 10-year excessive, amid gradual border re-openings between states.
Apart from power stocks, all main sub-indexes had been buying and selling in constructive territory.
Monitoring friends in the US, native healthcare stocks led positive aspects, leaping as a lot as 2.4%. Shares of Healius rose essentially the most, hitting their highest in over a month.
Tech stocks hit a report excessive, with positive aspects in Xero and Afterpay amongst prime boosts to the sub-index.
An in a single day dip in oil costs on surging infections and lockdown worries dragged the power index 0.6% decrease. Origin Power and Woodside Petroleum misplaced as much as 1.5% and 1.7%, respectively.
Nickel and gold miner IGO Ltd went into buying and selling halt earlier than asserting that it could take a 25% stake in Greenbushes lithium mine from China’s Tianqi for $1.Four billion.
Commonwealth Bank of Australia mentioned it could now fetch extra from the sale of its stake in a Chinese language life insurer to Japan’s Mitsui Sumitomo Insurance coverage Co after China’s banking regulator green-lit the deal.
C(BA)’s shares rose 1.6% to their highest in two weeks.
In New Zealand, the benchmark climbed as much as 1.5% and was set for its finest day in a month.
Infratil was the highest share gainer after rejecting a $3.78 billion buyout provide from AustralianSuper, calling out the bid for undervaluing its renewable power and digital infrastructure platforms. (Reporting by Arundhati Dutta in Bengaluru, Modifying by Sherry Jacob-Phillips)